Description: Overview: Vaccines are a cornerstone of preventive medicine, offering long-term or permanent immunity against diseases. They have been instrumental in near-eliminating many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Kalorama Information’s latest report, The World Market for Vaccines, 2024, provides a comprehensive analysis of adult and pediatric preventative vaccines, including market forecasts, company market share data, and expert market estimates for different vaccine categories. Length: 200 pages | Published Date: February 2024 Key Highlights:
- Market Analysis: Explore the market trends for human vaccines used to prevent various diseases, including commercialized vaccines and developmental vaccines for vaccine-preventable diseases.
- Emerging Vaccines: Learn about selected emerging vaccines in development and their potential impact on the market.
- Vaccine Categories: Gain insights into key vaccine categories, including combinations (tetanus, pertussis, Hib, Hepatitis, polio), HPV, influenza, meningitis, pandemic vaccines/COVID-19, pneumococcal, rotavirus, RSV, shingles, and others.
- Company Profiles: Understand the market landscape with profiles of key companies involved in vaccine development and distribution.
Scope and Methodology: The report covers human vaccines used to prevent various diseases, focusing on commercialized vaccines and developmental vaccines for vaccine-preventable diseases. It also includes a discussion of selected emerging vaccines and covers the COVID-19 vaccine market landscape. Sales estimates are provided for each market segment, representing global revenues expressed in current dollars, with estimates for 2023 and forecasts for 2028. Data was gathered from a variety of sources, including company reports, government documents, trade journals, and interviews with industry experts. Order Now: Stay informed about the latest trends and developments in the global vaccines market with The World Market for Vaccines, 2024. Order now to receive valuable insights that can help drive your business forward. For further details and to purchase directly, please contact us. Sample Report: A sample is available as a PDF upon request. Table: Global Market for Pediatric Preventive Vaccines, by Type, 2023–2028 (in millions $)
| Pediatric Vaccines | 2023 | 2028 | CAGR 2023-2028 |
| Hepatitis | $XX Million | $XX Million | XX% |
| Pediatric Routine (Combinations, HiB, MMR, Polio, Varicella) | $XX Million | $XX Million | XX% |
| Meningitis | $XX Million | $XX Million | XX% |
| Pneumococcal | $XX Million | $XX Million | XX% |
| Rotavirus | $XX Million | $XX Million | XX% |
| Influenza | $XX Million | $XX Million | XX% |
| HPV | $XX Million | $XX Million | XX% |
| Pandemic vaccines/COVID-19 | $XX Million | $XX Million | XX% |
| Others | $XX Million | $XX Million | XX% |
| Total | $XX Million | $XX Million | XX% |
Source: Kalorama Information
